Annual ROE
-70.70%
-18.67%-35.88%
December 1, 2023
Summary
- As of February 10, 2025, KNTE annual return on equity is -70.70%, with the most recent change of -18.67% (-35.88%) on December 1, 2023.
- During the last 3 years, KNTE annual ROE has fallen by -61.61% (-677.78%).
Performance
KNTE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-59.91%
+2.40%+3.85%
December 1, 2023
Summary
- As of February 10, 2025, KNTE quarterly return on equity is -59.91%, with the most recent change of +2.40% (+3.85%) on December 1, 2023.
- Over the past year, KNTE quarterly ROE has increased by +2.40% (+3.85%).
Performance
KNTE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KNTE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | +3.9% |
| 3 y3 years | -677.8% | +3.9% |
| 5 y5 years | +29.5% | +3.9% |
KNTE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +151.6% | at low | +133.7% | +4.0% |
| 5 y | 5-year | -203.3% | at low | -167.6% | +4.0% |
| alltime | all time | -203.3% | +41.8% | -167.6% | +4.0% |
Kinnate Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -70.70%(+35.9%) | -59.91%(-3.9%) |
| Sep 2023 | - | -62.31%(+9.3%) |
| Jun 2023 | - | -57.01%(+12.8%) |
| Mar 2023 | - | -50.53%(+13.1%) |
| Dec 2022 | -52.03%(+85.2%) | -44.66%(+14.5%) |
| Sep 2022 | - | -38.99%(+14.4%) |
| Jun 2022 | - | -34.09%(+13.2%) |
| Mar 2022 | - | -30.12%(+17.5%) |
| Dec 2021 | -28.10% | -25.64%(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -20.98%(+6.9%) |
| Jun 2021 | - | -19.63%(+22.8%) |
| Mar 2021 | - | -15.99%(+22.1%) |
| Dec 2020 | -9.09%(-113.3%) | -13.10%(-66.0%) |
| Sep 2020 | - | -38.51%(-143.5%) |
| Jun 2020 | - | 88.63%(+96.6%) |
| Mar 2020 | - | 45.08%(+100.0%) |
| Dec 2019 | 68.45%(-168.3%) | 22.54% |
| Dec 2018 | -100.26% | - |
FAQ
- What is Kinnate Biopharma annual return on equity?
- What is the all time high annual ROE for Kinnate Biopharma?
- What is Kinnate Biopharma annual ROE year-on-year change?
- What is Kinnate Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Kinnate Biopharma?
- What is Kinnate Biopharma quarterly ROE year-on-year change?
What is Kinnate Biopharma annual return on equity?
The current annual ROE of KNTE is -70.70%
What is the all time high annual ROE for Kinnate Biopharma?
Kinnate Biopharma all-time high annual return on equity is 68.45%
What is Kinnate Biopharma annual ROE year-on-year change?
Over the past year, KNTE annual return on equity has changed by -18.67% (-35.88%)
What is Kinnate Biopharma quarterly return on equity?
The current quarterly ROE of KNTE is -59.91%
What is the all time high quarterly ROE for Kinnate Biopharma?
Kinnate Biopharma all-time high quarterly return on equity is 88.63%
What is Kinnate Biopharma quarterly ROE year-on-year change?
Over the past year, KNTE quarterly return on equity has changed by +2.40% (+3.85%)